Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Affiliation country
Publication year range
1.
Acupunct Med ; : 9645284231210582, 2023 Dec 30.
Article in English | MEDLINE | ID: mdl-38159070

ABSTRACT

BACKGROUND: Acupuncture is a potentially effective non-pharmacological treatment for insomnia. OBJECTIVE: We observed the responses of patients with insomnia to acupuncture in routine clinical practice. In addition, we explored patient characteristics that might affect the treatment response to acupuncture for insomnia. METHODS: Medical records of patients with insomnia in a Korean medicine clinic with baseline Insomnia Severity Index (ISI) scores ⩾8 and Pittsburgh Sleep Quality Index (PSQI) scores ⩾5 were reviewed. Acupuncture was applied at ST43, GB41, ST41, SI5, HT3, KI10, HT7 and ST3, for 1-2 months. The ISI and PSQI were measured monthly to assess insomnia severity. The effect of acupuncture over time was analyzed using a multilevel linear model for repeated measures. In addition, logistic regression was used to explore predictors of treatment response. RESULTS: A total of 91 patients with insomnia aged 59.2 ± 12.5 years (mean ± standard deviation (SD)) (90.1% female) were included in the analysis. After the acupuncture treatment, ISI scores were significantly reduced by -3.75 (95% confidence interval (CI) = -4.99, -2.50) and -4.69 (95% CI = -6.22, -3.16) after the first and second month, respectively. The PSQI global scores also improved, and sleep duration showed a tendency to increase by 0.35 h (95% CI = -0.17, 0.86) after acupuncture treatment. Three cases of mild fatigue were reported. In addition, higher baseline pain/discomfort predicted a greater likelihood of response after acupuncture treatment (odds ratio (OR) = 1.66, 95% CI = 1.10, 2.60). CONCLUSION: In a real-world setting, the insomnia of outpatients in a clinic was slightly alleviated after acupuncture treatment. These findings require validation by randomized controlled trials.

2.
BMJ Open ; 13(7): e070252, 2023 07 14.
Article in English | MEDLINE | ID: mdl-37451728

ABSTRACT

INTRODUCTION: Among chronic diseases affecting older adults, metabolic syndrome (MetS) is known to be closely related to sarcopenia. Insulin resistance may play a key role in the increased frequency of sarcopenia associated with metabolic disorders. To date, an exercise-nutrition combined intervention has been the treatment of choice for sarcopenia. However, trials of combined interventions for individuals with sarcopenia and MetS are still lacking. This study aims to develop and conduct a standardised intervention, named the Multidisciplinary combined Exercise and Nutrition inTervention fOR Sarcopenia (MENTORS), for sarcopenic older patients with MetS. METHODS AND ANALYSIS: This multicentre, randomised controlled trial includes 168 community-dwelling older adults with sarcopenia and MetS. The 12-week MENTORS comprises an exercise intervention consisting of an introductory phase (3 weeks; twice-weekly visits), an expanded phase (3 weeks; twice-weekly visits) and a maintenance phase (6 weeks; once-weekly visits); and a nutrition intervention tailored to the nutritional status of individual subjects. Outcomes will be measured at 0-week, 12-week and 24-week postintervention. The data will be analysed using the intention-to-treat and per-protocol principle. ETHICS AND DISSEMINATION: Before screening, all participants will be provided with oral and written information. Ethical approval has already been obtained from all participating hospitals. The study results will be disseminated in peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: NCT04948736.


Subject(s)
Metabolic Syndrome , Sarcopenia , Humans , Aged , Sarcopenia/complications , Sarcopenia/therapy , Metabolic Syndrome/complications , Metabolic Syndrome/therapy , Exercise , Independent Living , Nutritional Status , Quality of Life , Randomized Controlled Trials as Topic , Multicenter Studies as Topic
3.
Arch Gerontol Geriatr ; 102: 104758, 2022.
Article in English | MEDLINE | ID: mdl-35777246

ABSTRACT

OBJECTIVES: This study examined whether leucine-rich protein supplements improve muscle strength, mass, and performance in sarcopenic older adults. METHODS: We searched PubMed-Medline, Embase, and Cochrane Library databases for randomized controlled trials comparing leucine-rich protein supplements with a control intervention in sarcopenic older adults. A pairwise meta-analysis using a fixed-effects model was performed. The primary outcome of interest was muscle strength regardless of the measures used. Effect sizes were computed as standardized mean differences (SMDs) with 95% confidence intervals (CIs). RESULTS: Six randomized controlled trials including a total of 699 participants were retrieved. Leucine-rich protein supplements improved participants' overall muscle strength, mass, and performance compared to the control group (SMD = 0.939; 95% CI, 0.440-1.438; P < 0.001). As the primary outcome, muscle strength improved significantly in the leucine group (SMD = 0.794; 95% CI, 0.104-1.485; P = 0.024). CONCLUSION: Leucine-rich protein supplements improve muscle strength in sarcopenic older adults. They may be suggested in nutritional treatment of sarcopenia.


Subject(s)
Sarcopenia , Aged , Dietary Supplements , Humans , Leucine/pharmacology , Leucine/therapeutic use , Muscle Strength/physiology , Muscle, Skeletal/physiology , Randomized Controlled Trials as Topic , Sarcopenia/drug therapy
4.
Nutrients ; 13(6)2021 Jun 11.
Article in English | MEDLINE | ID: mdl-34208333

ABSTRACT

We aimed to investigate the changes in vitamin D levels and factors associated with vitamin D deficiency (VDD) during the first year of life in Korean preterm infants. We enrolled 333 preterm infants who were born at Kyungpook National University Children's Hospital between March 2013 and December 2019. 25-hydroxyvitamin D (25-OHD) levels and medical records were collected at birth, 6 months, and 12 months of age. The mean gestational age was 33.4 ± 2.3 weeks and mean 25-OHD levels at birth were 18.2 ± 13.5 ng/mL. The incidence of VDD was 82.8%, 30.6%, and 27.0% at birth, 6 months, and 12 months, respectively. The incidence of severe VDD (25-OHD < 10 ng/mL) was 31.5%, 1.5%, and 0%, at birth, 6 months, and 12 months, respectively. Among infants with severe VDD, the deficiency persisted in 49.6% at 6 months, and 35.3% at 12 months. The strongest predictor of VDD during follow-up was 25-OHD concentration at birth. Vitamin D supplementation at 400 IU/day did not affect vitamin D levels during the first year of life. Therefore, it is important to prevent neonatal VDD through maternal vitamin D supplementation during pregnancy. Further research is needed to determine the optimal vitamin D supplementation dose for Korean preterm infants.


Subject(s)
Infant, Premature, Diseases/epidemiology , Vitamin D Deficiency/epidemiology , Vitamin D/analogs & derivatives , Female , Gestational Age , Humans , Incidence , Infant , Infant, Newborn , Infant, Premature/blood , Male , Risk Factors , Vitamin D/blood , Vitamins/blood
5.
Medicine (Baltimore) ; 100(24): e26421, 2021 Jun 18.
Article in English | MEDLINE | ID: mdl-34128906

ABSTRACT

INTRODUCTION: Spinal sarcopenia is a multifactorial disorder associated with the atrophy of and fatty changes to the paraspinal muscles. We previously developed the concept of spinal sarcopenia in community-dwelling older adults and investigated the association between conventional sarcopenic indices and spinal sarcopenia. However, interventional studies of spinal sarcopenia are lacking. This pilot study will aim to evaluate the effectiveness of a combined exercise and nutrition intervention for treating spinal sarcopenia. METHODS AND ANALYSIS: This open-label single-arm prospective study will include 35 community-dwelling older women who were diagnosed with spinal sarcopenia in our previous cohort study. The 12-week combined intervention will consist of back extensor strengthening exercise and nutritional supplementation. The primary outcome of this study will be isometric back extensor strength after the 12-week intervention. All functional and radiographic outcomes will be measured at 0, 12, and 24 weeks post-intervention. The data will be analyzed using the intention-to-treat principle.


Subject(s)
Dietary Supplements , Exercise Therapy/methods , Paraspinal Muscles/pathology , Resistance Training , Sarcopenia/therapy , Aged , Female , Humans , Independent Living , Muscle Strength , Pilot Projects , Sarcopenia/diet therapy
6.
Int J Mol Sci ; 19(2)2018 Feb 22.
Article in English | MEDLINE | ID: mdl-29470444

ABSTRACT

Abstract: Citrons have been widely used for medicinal purposes for a long time, but the application of citron in the food industry is still restricted. The extensive advantages of nanotechnology in the food industry have greatly broadened the application of foods. In this study, by employing nanotechnology, we prepared citron-extract nanoparticle with an average size of 174.11 ± 3.89 nm, containing protein peptide and/or liposome. In order to evaluate the toxicity of nanoparticles and to ensure food safety, biological cytotoxicity at the cell and genomic levels was also identified to examine the toxicity of citron extracts by using an in vitro system. Our results demonstrated that the cytotoxicity of citronliposome was dependent on cell type in high concentrations (1 and 5 mg/mL), selectively against primary human cardiac progenitor cells (hCPCs), and human endothelial progenitor cells (hEPCs) in MTT and lactate dehydrogenase (LDH) assays. Interestingly, for the NIH-3T3 and H9C2 cell lines, cell cytotoxicity was observed with slight genotoxicity, especially from citronpeptide extract for both cell lines. Taken together, our study provides cytotoxicity data on nanoengineered citron extracts according to different cell type as is crucial for further applications.


Subject(s)
Citrus/chemistry , Liposomes/chemistry , Peptides/pharmacology , Plant Extracts/pharmacology , Animals , Cell Death/drug effects , Cell Line , Cell Survival/drug effects , Comet Assay , Humans , L-Lactate Dehydrogenase/metabolism , Mice , Mutagens/toxicity , Nanoparticles
7.
Nature ; 550(7674): 87-91, 2017 10 04.
Article in English | MEDLINE | ID: mdl-28980632

ABSTRACT

Medical X-ray imaging procedures require digital flat detectors operating at low doses to reduce radiation health risks. Solution-processed organic-inorganic hybrid perovskites have characteristics that make them good candidates for the photoconductive layer of such sensitive detectors. However, such detectors have not yet been built on thin-film transistor arrays because it has been difficult to prepare thick perovskite films (more than a few hundred micrometres) over large areas (a detector is typically 50 centimetres by 50 centimetres). We report here an all-solution-based (in contrast to conventional vacuum processing) synthetic route to producing printable polycrystalline perovskites with sharply faceted large grains having morphologies and optoelectronic properties comparable to those of single crystals. High sensitivities of up to 11 microcoulombs per air KERMA of milligray per square centimetre (µC mGyair-1 cm-2) are achieved under irradiation with a 100-kilovolt bremsstrahlung source, which are at least one order of magnitude higher than the sensitivities achieved with currently used amorphous selenium or thallium-doped cesium iodide detectors. We demonstrate X-ray imaging in a conventional thin-film transistor substrate by embedding an 830-micrometre-thick perovskite film and an additional two interlayers of polymer/perovskite composites to provide conformal interfaces between perovskite films and electrodes that control dark currents and temporal charge carrier transportation. Such an all-solution-based perovskite detector could enable low-dose X-ray imaging, and could also be used in photoconductive devices for radiation imaging, sensing and energy harvesting.


Subject(s)
Calcium Compounds/chemistry , Oxides/chemistry , Printing , Radiation Dosage , Radiography/instrumentation , Radiography/methods , Titanium/chemistry , X-Rays , Cesium/chemistry , Electrodes , Equipment Design , Iodides/chemistry , Phantoms, Imaging , Selenium/chemistry , Thallium/chemistry , Transistors, Electronic
8.
Int J Mol Sci ; 18(3)2017 Mar 22.
Article in English | MEDLINE | ID: mdl-28327532

ABSTRACT

Soybean-derived isoflavones have been investigated for their preventative effects against UV-induced symptoms of skin damage including wrinkle formation and inflammation. Haematococcus pluvialis is a freshwater species of Chlorophyta that contains high concentrations of the natural carotenoid pigment astaxanthin. Astaxanthin is known to be involved in retinoic acid receptor (RAR) signaling and previously been associated with the inhibition of activator protein (AP)-1 dependent transcription. Based on previous studies, we hypothesized that a combination of soy extract (SE) and Haematococcus extract (HE) may prevent UVB-induced photoaging through specific signaling pathways, as measured by UVB-induced wrinkling on hairless mice skin and expression changes in human dermal fibroblasts (HDFs). The 1:2 ratio of SE and HE mixture (SHM) showed the optimal benefit in vivo. SHM was found to inhibit wrinkle formation via the downregulation of matrix metalloproteinase (MMP)-1 mRNA and protein expression. SHM also inhibited mitogen-activated protein kinase (MAPK) phosphorylation and the transactivation of AP-1 which plays an important role in regulating MMP expression. These results highlight the potential for SHM to be developed as a therapeutic agent to prevent UVB-induced skin wrinkling.


Subject(s)
Chlorophyta/chemistry , Glycine max/chemistry , Plant Extracts/pharmacology , Skin Aging/drug effects , Skin Aging/radiation effects , Ultraviolet Rays/adverse effects , Administration, Oral , Animals , Cellular Senescence/drug effects , Cellular Senescence/radiation effects , Collagen/metabolism , Epidermis/drug effects , Epidermis/metabolism , Epidermis/pathology , Epidermis/radiation effects , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/radiation effects , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 1/metabolism , Mice , Mice, Nude , Plant Extracts/administration & dosage , Proteolysis , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Signal Transduction/radiation effects , Time Factors , Tissue Inhibitor of Metalloproteinase-1/metabolism
9.
Toxicol Res ; 32(3): 207-13, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27437087

ABSTRACT

Although propolis is one of the most popular functional foods for human health, there have been no comprehensive studies of herb-drug interactions through cytochrome P450 (CYP) inhibition. The purpose of this study was to determine the inhibitory effects of propolis on the activities of CYP1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1 and 3A4 using pooled human liver microsomes (HLMs). Propolis inhibited CYP1A2, CYP2E1 and CYP2C19 with an IC50 value of 6.9, 16.8, and 43.1 µg/mL, respectively, whereas CYP2A6, 2B6, 2C9, 2D6, and 3A4 were unaffected. Based on half-maximal inhibitory concentration shifts between microsomes incubated with and without nicotinamide adenine dinucleotide phosphate, propolis-induced CYP1A2, CYP2C19, and CYP2E1 inhibition was metabolism-independent. To evaluate the interaction potential between propolis and therapeutic drugs, the effects of propolis on metabolism of duloxetine, a serotonin-norepinephrine reuptake inhibitor, were determined in HLMs. CYP1A2 and CYP2D6 are involved in hydroxylation of duloxetine to 4-hydroxy duloxetine, the major metabolite, which was decreased following propolis addition in HLMs. These results raise the possibility of interactions between propolis and therapeutic drugs metabolized by CYP1A2.

10.
J Agric Food Chem ; 64(27): 5508-14, 2016 Jul 13.
Article in English | MEDLINE | ID: mdl-27321552

ABSTRACT

Though Dieckol, a phlorotannin of Ecklonia cava, was known to have antioxidant, anticancer, antidiabetic, and anti-inflammatory effects, the underlying antifibrotic mechanism of Dieckol still remains unclear until now. Thus, in the current study, the inhibitory mechanism of Dieckol on liver fibrosis was elucidated mainly in hepatic stellate cells (HSCs). Dieckol exerted cytotoxicity in LX-2, HSC-T6, and HepG2 cells with the reduced fibrosis features of large, spread out, and flattened polygonal shapes in LX-2 cells compared to untreated control. Dieckol attenuated the expression of α-SMA and TGF-ß1, increased sub-G1 phase population, and induced caspase-3 activation and cleavages of PARP in HSCs. Furthermore, Dieckol decreased phosphorylation of ERK, p38, AKT, NF-kB, and IkB and activated the microRNA(miR)134 level and JNK phosphorylation in HSCs. Conversely, JNK inhbitor SP600125 reversed the effect of Dieckol on PARP, p-NF-kB, α -SMA, and p-JNK in LX-2 cells. Likewise, miR134 overexpression mimic enhanced phosphorylation of JNK and NF-kB and reduced the expression of α-SMA and PARP cleavage, while miR134 inhibitor reversed the ability of Dieckol to cleave PARP and attenuate the expression of α-SMA in LX-2 cells. Overall, our findings suggest that Dieckol suppresses liver fibrosis via caspase activation and miR134 mediated JNK activation and NF-kB inhibition.


Subject(s)
Benzofurans/pharmacology , Liver Cirrhosis/metabolism , MAP Kinase Kinase 4/metabolism , MicroRNAs/metabolism , NF-kappa B/metabolism , Phaeophyceae/chemistry , Plant Extracts/pharmacology , Animals , Cell Line , Down-Regulation/drug effects , Hepatic Stellate Cells/drug effects , Hepatic Stellate Cells/metabolism , Humans , Liver Cirrhosis/drug therapy , Liver Cirrhosis/genetics , MAP Kinase Kinase 4/genetics , Mice , MicroRNAs/genetics , NF-kappa B/genetics , Signal Transduction/drug effects
11.
Chemosphere ; 153: 426-35, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27031806

ABSTRACT

Legacy and new persistent organic pollutants (POPs) and polycyclic aromatic hydrocarbons (PAHs) were measured in sediments near a wastewater treatment plant (WWTP) outfall in a semi-enclosed bay, to investigate the current contamination and temporal changes in these contaminants associated with regulation activities in Korea. The concentrations of most of the POPs showed clear decreasing trends with an increase in the distance from the WWTP outfall, indicating that the WWTP discharges greatly contributed to the sediment contamination by POPs. Highly significant correlations were found for most of the POPs, indicating a common source for sediment contamination. Significant declines were found in the concentrations of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), dioxin-like polychlorinated biphenyls (DL-PCBs), polybrominated diphenyl ethers (PBDEs), and PAHs in the sediments collected between 2005 and 2013. This result suggested that legislative actions (regulation of the PCDD/Fs in flue gas, total pollution load management, and whole effluent toxicity for WWTP discharges) and change of fuels, were likely to be effective at reducing the POP and PAH levels in sediments during the past several years. The different compositional profiles of the PCDD/Fs and PAHs between 2005 and 2013 implied changes in and/or additional sources of these contaminants. Despite a decline in the PCDD/Fs over time, the present levels of PCDD/Fs in the sediment exceeded some of the sediment quality guidelines suggested by the National Oceanic and Atmospheric Administration.


Subject(s)
Environmental Restoration and Remediation/legislation & jurisprudence , Geologic Sediments/analysis , Waste Disposal, Fluid , Water Pollution, Chemical/prevention & control , Environmental Monitoring , Republic of Korea , Wastewater/analysis
12.
Brain Res ; 1629: 63-71, 2015 Dec 10.
Article in English | MEDLINE | ID: mdl-26459992

ABSTRACT

Self-transcendence is an inherent human personality trait relating to the experience of spiritual aspects of the self. We examined the relationship between self-transcendence and serotonin transporter (SERT) availability in brainstem raphe nuclei, which are collections of five different serotonergic nuclei with rostro-caudal extension, using ultra-high resolution magnetic resonance imaging (MRI) and positron emission tomography (PET) with (11)C-3-amino-4-(2-dimethylaminomethylphenylthio)benzonitrile ([(11)C]DASB) to elucidate potential roles of serotonergic neuronal activities in this personality trait. Sixteen healthy subjects completed 7.0T MRI and High Resolution Research Tomograph (HRRT) PET. The regions of interest (ROIs) included the dorsal raphe nucleus (R1), median raphe nucleus (R2), raphe pontis (R3), and the caudal raphe nuclei (R4 and R5). For the estimation of SERT availability, the binding potential (BPND) was derived using the simplified reference tissue model (SRTM2). The Temperament and Character Inventory was used to measure self-transcendence. The analysis revealed that the self-transcendence total score had a significant negative correlation with the [(11)C]DASB BPND in the caudal raphe (R5). The subscale score for spiritual acceptance was significantly negatively correlated with the [(11)C]DASB BPND in the median raphe nucleus (R2). The results indicate that the self-transcendence trait is associated with SERT availability in specific raphe subnuclei, suggesting that the serotonin system may serve as an important biological basis for human self-transcendence. Based on the connections of these nuclei with cortico-limbic and visceral autonomic structures, the functional activity of these nuclei and their related neural circuitry may play a crucial role in the manifestation of self-transcendence.


Subject(s)
Brain Stem/metabolism , Dorsal Raphe Nucleus/metabolism , Magnetic Resonance Imaging/methods , Positron-Emission Tomography/methods , Serotonin Plasma Membrane Transport Proteins/metabolism , Spirituality , Adult , Brain Stem/diagnostic imaging , Dorsal Raphe Nucleus/diagnostic imaging , Female , Humans , Male , Middle Aged , Self Concept , Young Adult
13.
Arch Pharm Res ; 38(5): 691-704, 2015.
Article in English | MEDLINE | ID: mdl-25336106

ABSTRACT

Although various in vitro assays have been developed to evaluate the cytochrome P450 (CYP)-inducing potential of drug candidates, there is a continuing need for the development of a reliable model in drug discovery. The objective of the present study was to compare CYP induction by chemicals in HepG2 cells with Huh7, NKNT-3, and reverted NKNT-3 cells. HepG2 cells showed more similarity to human liver than the other cell lines in comparisons of the expression of cellular proteins. In evaluation of basal CYP activity, Huh7 cells exhibited the highest CYP1A2 and CYP3A4 activity, and HepG2 cells showed the highest CYP2B6 activity. The inducibility of CYP1A2, CYP2B6, and CYP3A4 by prototypical inducers was determined using enzyme assay, immunoblot analysis, and real-time PCR. Among the cells tested, HepG2 cells were highly responsive to CYP inducers, such as 3-methylcholanthrene for CYP1A2 and phenobarbital for CYP2B6 and CYP3A4. Moreover, HepG2 cells were responsive to various CYP1A2, CYP2B6, and CYP3A4 inducers as determined using fluorogenic and LC-MS/MS substrates. Thus, HepG2 cells may be comparable to human hepatocytes for the evaluation of CYP induction or slightly less sensitive. These results suggest HepG2 cells as a cell-based model in screening for CYP inducers in drug discovery.


Subject(s)
Cytochrome P-450 Enzyme Inducers/pharmacology , Hepatocytes/drug effects , Hepatocytes/enzymology , Xenobiotics/pharmacology , Cell Line, Transformed , Drug Evaluation, Preclinical/methods , Enzyme Induction/drug effects , Enzyme Induction/physiology , Hep G2 Cells , Humans
14.
Psychiatry Res ; 231(1): 50-7, 2015 Jan 30.
Article in English | MEDLINE | ID: mdl-25465315

ABSTRACT

The serotonin transporter (SERT) is an integral protein that provides an index of serotonergic innervation. Until recently, few studies have investigated SERT binding in thalamic subregions in schizophrenia. The purpose of this study was to examine SERT availability in thalamic subdivisions (anterior nucleus, mediodorsal nucleus, and pulvinar) using 7.0-T magnetic resonance imaging (MRI) and high-resolution positron emission tomography (PET) with (11)C-3-amino-4-(2-dimethylaminomethylphenylthio)benzonitrile ([(11)C]DASB) in schizophrenia. Antipsychotic-free patients with schizophrenia (n=12) and healthy controls (n=15) underwent PET and MRI scans. For SERT availability, the binding potential with respect to non-displaceable compartment (BPND) was derived using the simplified reference tissue model (SRTM2). The analysis revealed that there were no significant differences in SERT availability between the two groups. In patients with schizophrenia, the severity of negative symptoms had a negative correlation with SERT availability in the anterior nucleus of the left thalamus. The present study did not reveal significant differences in SERT availability in thalamic subdivisions between patients with schizophrenia and control subjects. The association of SERT availability in the anterior nucleus with negative symptoms may suggest a role for the anterior thalamic nucleus in the pathophysiology of symptoms of schizophrenia. The ultra-high resolution imaging system could be an important asset for in vivo psychiatric research by combining structural and molecular information.


Subject(s)
Aniline Compounds , Brain/metabolism , Positron-Emission Tomography , Schizophrenia/diagnostic imaging , Serotonin Plasma Membrane Transport Proteins/metabolism , Sulfides , Thalamus/metabolism , Adult , Brain/drug effects , Case-Control Studies , Female , Humans , Image Processing, Computer-Assisted/methods , Magnetic Resonance Imaging , Male , Membrane Transport Proteins/metabolism , Middle Aged , Schizophrenia/metabolism
15.
Xenobiotica ; 45(2): 131-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25145883

ABSTRACT

1. The herb-drug interaction potential of Hwang-Ryun-Hae-Dok-Tang (HR) extracts mediated by cytochrome P450 (CYP) inhibition was determined using human liver microsomes. 2. HR strongly inhibited CYP1A2 and moderately inhibited CYP2C19, CYP2D6, and CYP3A4 (testosterone) but not CYP2A6, CYP2B6, CYP2C8, CYP2C9, and CYP3A4 (midazolam). 3. The enzyme kinetic results suggest that CYP1A2 inhibition is competitively reversible (Ki, 13.4±1.8 µg/ml), and CYP2D6 inhibition is quasi-irreversible (KI, 0.234±0.138 µg/ml; kinact, 0.067±0.006 min(-1)). 4. Fermentation using Lactobacillus acidophilus attenuated the HR-induced inhibition of CYP2D6, but not the other isoforms. 5. Neither CYP1A2 nor CYP3A4 was markedly inhibited by berberine, palmatine, and geniposide-major components in HR-and CYP2D6 was inhibited by berberine (IC50, 13.8 µg/ml) in a metabolism-dependent manner. 6. The results suggest the possibility of HR-drug interaction through inhibition of CYP-particularly CYP2D6-which may be attenuated by fermentation using L. acidophilus.


Subject(s)
Cytochrome P-450 Enzyme Inhibitors/pharmacology , Cytochrome P-450 Enzyme System/chemistry , Drugs, Chinese Herbal/pharmacology , Microsomes, Liver/enzymology , Cytochrome P-450 Enzyme Inhibitors/chemistry , Drugs, Chinese Herbal/chemistry , Fermentation , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Kinetics , Lactobacillus acidophilus/metabolism
16.
Int J Hyg Environ Health ; 217(8): 871-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25043456

ABSTRACT

This study evaluated blood lead concentrations in the Korean general population and the correlation between various exposure sources using data from the 2008 Korea National Survey for Environmental Pollutants in the Human Body (National Institute of Environmental Research, Korea). The general and occupational characteristics were gathered from 5136 participants who were 20 years of age and older using a structured questionnaire. Blood lead concentrations were analyzed using an atomic absorption spectrophotometer. Statistical analysis was performed using multiple linear regressions of the log lead concentrations to the independent variables such as age, gender, smoke, herbal medication and drug consumption, drinking water, and living area. Geometric mean (GM) blood lead concentrations in Korean adults were 19.7 µg/l. The blood lead concentrations increased with age; the highest concentrations were found in the 50-69-year age group (p<0.001). Males were higher than in females (p<0.001). Current smokers and drinkers had higher concentrations than nonsmokers (p<0.001) and nondrinkers (p<0.001), respectively. People who took herbal medication and drug consumption were higher than those who did not (p<0.001). Education level was negatively associated with blood lead concentration (p<0.001). People living in or around industrial areas had elevated blood lead concentration (p<0.001). Family income was also negatively associated with lead concentration, but not significantly. For drinking water, the underground water (spring or well water) drinking group had higher concentrations than other types of water drinking groups, but not significantly (p=0.063). The blood lead concentrations by occupation were significant (p<0.034): the highest was in laborer and Agricultural-Fishery-Forestry and the lowest in office workers. In women, blood lead concentrations tended to decrease with increasing delivery times, but not significantly. The blood lead concentration (GM) of the general adult population in Korea has decreased over time from 45.8 µg/l (1999) to 19.7 µg/l (2008). Although it is still higher than in other countries such as the United States and Canada, it is rapidly decreasing. Gender, age, smoking and alcohol drinking status, herbal medication and drug consumption, education level, living area and occupation were significantly related to the blood lead concentrations in Korea.


Subject(s)
Environmental Exposure/analysis , Environmental Pollutants/blood , Lead/blood , Adult , Age Factors , Aged , Alcohol Drinking , Drinking Water , Educational Status , Female , Humans , Linear Models , Male , Middle Aged , Occupations , Pharmaceutical Preparations/administration & dosage , Plant Extracts/administration & dosage , Republic of Korea , Residence Characteristics , Sex Factors , Smoking , Spectrophotometry, Atomic , Surveys and Questionnaires , Young Adult
17.
Int J Mol Med ; 33(2): 469-77, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24336971

ABSTRACT

In this study, we investigated the anti-allergic action of mulberry fruit extract (MFE) or MFE in combination with naringinase (MFEN) in IgE-activated RBL-2H3 cells, and investigated the mechanisms responsible for the anti-allergic effects of MFEN. ß-hexosaminidase release assay was used to measure the amount of ß-hexosaminidase released from the cells, and ELISA was used to measure the levels of tumor necrosis factor-α (TNF-α). We found that MFE significantly reduced the release of ß-hexosaminidase (IC(50), 10.59 mg/ml) and TNF-α (IC(50), 4.87 mg/ml). Moreover, MFEN enhanced the inhibitory effects on the release of ß-hexosaminidase (IC(50), 123.10 µg/ml) and TNF-α (IC(50), 65.01 µg/ml). Furthermore, MFEN had no cytotoxicity at the concentration range used to exert the anti-allergic effects. In addition, we evaluated the effects of MFEN on the formation of pro-inflammatory lipid mediators, such as prostaglandin D(2) (PGD(2)), leukotriene C(4) (LTC(4)) and leukotriene B(4) (LTB(4)) using enzyme immunoassay (EIA) kits. MFEN markedly reduced the formation of PGD(2) (IC(50), 6.47 µg/ml) and LTC(4) (IC(50), 0.31 µg/ml), but not LTB(4) (IC(50), 25.75 µg/ml). In mechanistic analyses, we measured the phosphorylation of Syk, Lyn and Fyn by immunoblot analysis. MFEN significantly inhibited the phosphorylation of Syk, but not that of Lyn or Fyn. MFEN also suppressed the phosphorylation of phospholipase C (PLC)γ1/2, protein kinase C (PKC)δ, linker for activation of T cells (LAT), extracellular signal-regulated protein kinase (ERK)1/2, JNK, GRB2-associated binding protein 2 (Gab2), phosphoinositide-3-kinase (PI3K), Akt, cytosolic phospholipase A2 and 5-lipoxygenase, as well as the expression of cyclooxygenase-2. In conclusion, these results suggest that MFEN exerts potent inhibitory effects on allergic response through the suppression of the activation of the FcεRI signaling cascade. Our data demonstrating the anti-allergic effects of MFEN may provide further insight into the therapeutic application of MFEN or its use as a functional food.


Subject(s)
Anti-Allergic Agents/pharmacology , Fruit/chemistry , Immunoglobulin E/metabolism , Morus/chemistry , Multienzyme Complexes/metabolism , Plant Extracts/pharmacology , beta-Glucosidase/metabolism , Animals , Cell Line, Tumor , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Hypersensitivity/drug therapy , Inhibitory Concentration 50 , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins c-akt , Proto-Oncogene Proteins c-fyn/genetics , Proto-Oncogene Proteins c-fyn/metabolism , Rats , Rats, Wistar , Signal Transduction , Syk Kinase , Tumor Necrosis Factor-alpha/metabolism , src-Family Kinases/genetics , src-Family Kinases/metabolism
18.
Food Chem Toxicol ; 51: 343-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23104244

ABSTRACT

We evaluated the herb-drug interaction potential of Galgeun-tang (GGT) extracts, mediated by cytochrome P450 (CYP) inhibition/induction. Further, the effects of fermentation on the CYP-mediated herb-drug interaction potential of GGT extracts were determined. As measured by LC-ESI/MS/MS, GGT extracts (0-300µg/mL) showed no inhibitory activity toward eight CYP isoforms (1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1, and 3A4) in pooled human liver microsomes, suggesting that GGT may have low potential for herb-drug interactions mediated by CYP inhibition. Hepatic CYP expression and activity in rats treated with GGT extracts twice per day for 1week was examined. Among the tested CYP isoforms (1A1, 1A2, 1B1, 2B1, 2C11, 2E1, 3A1, 3A2, and 4A1), CYP1B1 and 4A1 were increased by GGT extracts. Hepatic activities of 7-ethoxyresorufin-O-deethylase, 7-pentoxyresorufin-O-depentylase, and chlorzoxazone 6-hydroxylase, but not midazolam hydroxylase were also elevated. These results raise the possibility that GGT extracts may increase the toxicity of environmental toxicants through the elevating CYP-dependent metabolic activation. Interestingly, the increases in CYP1B1 and CYP4A1 levels, and 7-ethoxyresorufin-O-deethylase, 7-pentoxyresorufin-O-depentylase, and chlorzoxazone 6-hydroxylase activities were attenuated by fermentation of GGT extract using Lactobacillus plantarum KFRI 402, but not 144. Further studies are needed to identify the CYP regulatory component(s) from GGT and determination its metabolism.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Drugs, Chinese Herbal/pharmacology , Herb-Drug Interactions , Microsomes, Liver/drug effects , Animals , Aryl Hydrocarbon Hydroxylases , Biotransformation , Cytochrome P-450 CYP1A1/metabolism , Cytochrome P-450 CYP1B1 , Cytochrome P-450 Enzyme Inhibitors , Drugs, Chinese Herbal/pharmacokinetics , Fermentation , Liver/drug effects , Liver/enzymology , Male , Microsomes, Liver/metabolism , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry
19.
Food Chem ; 136(2): 450-7, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23122083

ABSTRACT

We have evaluated the herb-drug interaction potential of Ssang-hwa-tang (SHT) mediated by cytochrome P450 (CYP) inhibition/induction. Further, the effects of fermentation on the CYP-mediated herb-drug interaction potential were determined. SHT showed inhibitory activity toward CYP1A2, but not 2A6, 2B6, 2C9, 2C19, 2D6, 2E1, and 3A4 in human liver microsomes. The results of the enzyme kinetic study suggested that the SHT-induced CYP1A2 inhibition is mixed reversible inhibition. The hepatic CYP expression and activity in rats treated with SHT were examined. The expression/activity of CYP2E1 increased as a result of SHT extract treatment (P<0.005 or P<0.001, respectively), which raises the possibility that SHT may increase the toxicity of environmental toxicants through the elevation of CYP2E1-mediated metabolic activation. SHT fermentation using Lactobacillus fermentum or Lactobacillus gasseri resulted in attenuation of the SHT-induced CYP1A2 inhibition, but not CYP2E1 induction, suggesting that changes in the chemical composition of SHT through fermentation can affect the inhibition of CYP1A2 activity.


Subject(s)
Cytochrome P-450 Enzyme Inhibitors , Drugs, Chinese Herbal/adverse effects , Herb-Drug Interactions , Animals , Cytochrome P-450 Enzyme System/chemistry , Cytochrome P-450 Enzyme System/metabolism , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/metabolism , Fermentation , Humans , Kinetics , Lactobacillus/metabolism , Male , Microsomes, Liver/chemistry , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Rats , Rats, Sprague-Dawley
20.
Neuroreport ; 23(4): 228-33, 2012 Mar 07.
Article in English | MEDLINE | ID: mdl-22209803

ABSTRACT

Despite the importance of the adaptive process for discriminating the broad range of sound intensity, there have been few systemic investigations targeting the auditory mechanisms. In this study, the adaptation effect of sound intensity on the change in glucose metabolism in rat brains was examined using a PET technique. In the first experiment, broadband white noise sound (40, 60, 80, or 100 dB sound pressure level) was given for 30 min after an 2-[F-18]-fluoro-2-deoxy-D-glucose injection in an awake condition. In the second experiment, sound stimuli with an intensity modulation of 0, 0.5, and 5.0 Hz in frequency and at three intensity levels were used for examining the metabolism change according to the short time scale variation of the sound intensity. As a result, the metabolic activities in the bilateral cochlear nucleus, superior olivary complexes, and inferior colliculus were proportional to the sound intensity level, whereas the bilateral auditory cortical areas unexpectedly decreased as the sound intensity level increased in the first experiment. In the second experiment, the glucose metabolism in the auditory cortex was higher at 0.5 and 5.0 Hz modulation frequency than the 0.0 Hz modulation frequency, while retaining an inverse relationship with the sound intensity. The metabolism in inferior colliculus was higher at 5.0 Hz modulation frequency than 0.0 and 0.5 Hz modulation frequencies. Taken together, the auditory cortex metabolism seemed to be actively adapted to the average sound intensity, which indicates that it plays an important role in processing the broad range to sound intensity more than the other nucleus of the auditory pathway. Especially, this study demonstrated that the sound intensity-dependent glucose metabolism can be seen in a small rodent's brain stem level using 2-[F-18]-fluoro-2-deoxy-D-glucose PET functional neuroimaging.


Subject(s)
Adaptation, Physiological/physiology , Auditory Pathways/metabolism , Loudness Perception/physiology , Positron-Emission Tomography/methods , Acoustic Stimulation/methods , Animals , Auditory Pathways/anatomy & histology , Auditory Pathways/diagnostic imaging , Fluorodeoxyglucose F18 , Male , Rats , Rats, Sprague-Dawley , Sound
SELECTION OF CITATIONS
SEARCH DETAIL